Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $34.03 in the prior trading day, Viking Therapeutics Inc (NASDAQ: VKTX) closed at $31.88, down -6.32%. In other words, the price has decreased by -$6.32 from its previous closing price. On the day, 3.61 million shares were traded. VKTX stock price reached its highest trading level at $33.99 during the session, while it also had its lowest trading level at $31.3.
Ratios:
Our goal is to gain a better understanding of VKTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.86 and its Current Ratio is at 25.86. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $104.
On April 08, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $30.
On February 13, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $102.Scotiabank initiated its Sector Outperform rating on February 13, 2025, with a $102 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 03 ’25 when Lian Brian sold 26,889 shares for $27.80 per share. The transaction valued at 747,633 led to the insider holds 2,388,014 shares of the business.
ZANTE GREG sold 4,266 shares of VKTX for $118,428 on Jul 03 ’25. The Chief Financial Officer now owns 168,660 shares after completing the transaction at $27.76 per share. On Jul 03 ’25, another insider, Mancini Marianna, who serves as the Chief Operating Officer of the company, sold 4,266 shares for $27.77 each. As a result, the insider received 118,473 and left with 377,535 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 3826492416 and an Enterprise Value of 6362644480.
Stock Price History:
The Beta on a monthly basis for VKTX is 0.74, which has changed by -0.42836648 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $81.73, while it has fallen to a 52-week low of $18.92. The 50-Day Moving Average of the stock is 8.33%, while the 200-Day Moving Average is calculated to be -11.76%.
Shares Statistics:
The stock has traded on average 3.52M shares per day over the past 3-months and 4033770 shares per day over the last 10 days, according to various share statistics. A total of 112.33M shares are outstanding, with a floating share count of 109.09M. Insiders hold about 2.98% of the company’s shares, while institutions hold 69.31% stake in the company. Shares short for VKTX as of 1752537600 were 28599499 with a Short Ratio of 8.12, compared to 1749772800 on 28474422. Therefore, it implies a Short% of Shares Outstanding of 28599499 and a Short% of Float of 30.509999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
